Latest stories, analysis, and insights from the world of health.
Two medical experts argue that the surge in perimenopause awareness is fueling misinformation, portraying women as slaves to their hormones while selling them unproven products and supplements.
<UNKNOWN>
Mass General Brigham executives claim the health system has saved over 1,400 more lives through streamlined quality metrics and improved mortality ratios, but many doctors skeptically question whether the improvements result from actual clinical changes or administrative data adjustments like increased hospice enrollment and better clinical coding.
Biogen and Denali Therapeutics announced that their experimental LRRK2-targeting therapy failed to slow Parkinson's disease in a randomized trial of 648 patients, dealing a significant setback to the scientific approach and the patient community.
Melanoma skin cancer cases in the UK have exceeded 20,000 annually for the first time, with Cancer Research UK warning that nine in ten cases are preventable through sun safety measures.
Robert F. Kennedy Jr. issues a warning about excessive screen time and its potential health impacts.
Sexually transmitted infections including gonorrhoea and syphilis have reached their highest levels in over 10 years across Europe in 2024, with gonorrhoea cases increasing 303% since 2015, according to new data from the European Centre for Disease Prevention and Control.
From HelloFresh and Blue Apron to Marley Spoon and beyond, meal kits cater to many diets and budgets. We tested dozens of services to find the best options for your cooking style and dietary needs.
Sexually transmitted infections including gonorrhoea and syphilis have reached their highest levels in over 10 years across Europe in 2024, with gonorrhoea cases up 303% since 2015 and syphilis more than doubling, according to new data from the European Centre for Disease Prevention and Control.
Eli Lilly's retatrutide, a next-generation obesity drug, achieved weight loss approaching bariatric surgery effectiveness in Phase 3 trials, but high discontinuation rates due to side effects raise questions about its practical use.
Wearable maker Whoop has not resolved its dispute with the FDA over a blood pressure feature launched last year. The FDA warned Whoop in July 2025 that the feature requires regulatory review as a medical device, though Whoop argues it qualifies as a wellness product exempt from FDA oversight.
A comprehensive guide to the best yoga mats for every need, from premium options like Lululemon and Manduka to eco-friendly and travel-specific choices, with expert testing and recommendations.
A deadly Ebola outbreak in DR Congo's Ituri province is spreading faster than originally feared, with the WHO warning that cases may be significantly undercounted and have already spread across borders and to other provinces.
Senate and House Democrats introduced resolutions to overturn the WISeR Medicare pilot program, which uses artificial intelligence to approve or deny care. The effort follows a GAO ruling determining the program should have required congressional approval before implementation.
Democrats have pushed for a vote to end Medicare's AI-based prior authorization pilot program, citing concerns over delays in patient care and implementation challenges.
An Ebola outbreak in DR Congo's Ituri province has killed an estimated 136 people with over 514 suspected cases, as the WHO warns the virus may be spreading faster than initially detected, with fears it could exceed 1,000 cases.
After mass shootings, children who witnessed or were near the violence face significant risk of trauma and PTSD. Experts provide guidance for parents and caregivers on recognizing symptoms and helping children regain a sense of safety through open communication and coping techniques.
Senate and House Democrats introduced resolutions to overturn the WISeR Medicare pilot program that uses artificial intelligence to approve or deny care for seniors, following a GAO ruling that the program should have required Congressional approval.
After 25 years of research, UCSF researcher Tippi MacKenzie's team is moving closer to conducting the first FDA-approved in utero gene therapy trial, targeting a rare genetic disease in five fetal patients.
<UNKNOWN>